CircaDawn Red Light Panel
660nm + 850nm Photobiomodulation Panel
Stimulate your cells. Not your brain. The perfect evening companion to circadian lighting.
The CircaDawn Red Light Panel delivers dual-wavelength photobiomodulation at 660nm (red) and 850nm (near-infrared). Unlike blue-enriched white light, these wavelengths do not activate melanopsin photoreceptors in the retina, meaning they do not suppress melatonin. Used in the evening, the panel actively supports natural melatonin secretion while delivering clinically studied benefits for sleep, skin collagen, muscle recovery, and cellular energy production. No Wi-Fi, no app, no subscription — just plug in and use.
- Dual wavelength: 660nm (red) + 850nm (near-infrared)
- Does NOT suppress melatonin — safe for evening use
- Stimulates ATP production via cytochrome c oxidase (Karu 2010)
- Clinically studied: sleep, skin, muscle recovery, inflammation
- Brushed aluminium frame with protective LED mesh
- Wall-mountable or free-standing with included bracket
Free shipping on orders over R1,000 · 30-day returns · 2 years warranty
Technical Specifications
What's Included
- Dual wavelength: 660nm (red) + 850nm (near-infrared)
- Does NOT suppress melatonin — safe for evening use
- Stimulates ATP production via cytochrome c oxidase (Karu 2010)
- Clinically studied: sleep, skin, muscle recovery, inflammation
- Brushed aluminium frame with protective LED mesh
- Wall-mountable or free-standing with included bracket
- Timer-compatible — pairs with any standard plug-in timer
- No Wi-Fi, no app, no subscription required
- Flicker-free constant-current LED driver
- Suitable for home, clinic, and wellness studio use
"As a GP, I’ve been recommending red light therapy to patients with sleep disorders and chronic inflammation for two years. The CircaDawn panel is the first product I’ve found that combines clinical-grade wavelengths with a price point accessible to my patients. The results have been consistently positive."
Dr. Sarah M.
Cape Town · 660nm + 850nm Photobiomodulation Panel